Major Funding Boost for Ultrasound Brain-Computer Interface Technology
A startup developing AI-powered ultrasound brain-computer interface (BCI) technology has closed a seed+ funding round worth tens of millions of Chinese yuan. The investment was led by Guoqi Investment, with participation from Yuanhe Puhua, the Global Health Industry Innovation Center, and continued support from existing investors. Lighthouse Capital acted as the exclusive financial advisor.
Strategic Allocation of New Capital
The freshly acquired capital is earmarked for accelerating the company's key initiatives across multiple fronts.
- Core Technology R&D: Deepening investment in fundamental ultrasound BCI research to enhance precision and performance.
- Medical Device Advancement: Progressing the technology toward regulatory-ready medical product development and clinical application.
- Data & AI Platform: Building a multimodal brain data and AI-powered neuroscience platform to unlock insights from neural signals.
- Talent Expansion: Growing an interdisciplinary team spanning engineering, medicine, and algorithms to support long-term innovation.
The Ultrasound BCI Advantage
Unlike invasive implants or scalp-electrode-based systems, ultrasound BCI presents a promising non-invasive alternative with the potential for high spatial resolution. This technology leverages ultrasound waves to interact with neural activity for both sensing and modulation, aiming to enable safer, long-term brain-computer interaction. Integrating AI for decoding complex neural data is central to its progress.
This successful funding round provides substantial resources for the startup and signals growing investor confidence in next-generation, non-invasive neural interface approaches. As the race to advance brain science intensifies, solutions that combine cutting-edge ultrasound with artificial intelligence are positioning themselves to impact future healthcare, research, and human-computer interaction.